SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '4ydj'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID
Hit
Macromolecule
Res.
Matches
Interface HETATM RMSD Dali
Z-score
Seq.
Identity (%)
View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_A_KLNA1500_1
(CYTOCHROME P450 3A4)
4ydj HEAVY CHAIN OF
ANTIBODY 44-VRC13.01
LIGHT CHAIN OF
ANTIBODY 44-VRC13.01

(Homo
sapiens)
5 / 11 ILE H  35
ALA H  93
ARG L  53
GLU H 100
LEU L  46
None
1.27A 2v0mA-4ydjH:
undetectable
2v0mA-4ydjH:
18.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_D_KLND1498_1
(CYTOCHROME P450 3A4)
4ydj HEAVY CHAIN OF
ANTIBODY 44-VRC13.01
LIGHT CHAIN OF
ANTIBODY 44-VRC13.01

(Homo
sapiens)
5 / 11 ILE H  35
ALA H  93
ARG L  53
GLU H 100
LEU L  46
None
1.36A 2v0mD-4ydjH:
undetectable
2v0mD-4ydjH:
18.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2Y7P_A_SALA1000_1
(LYSR-TYPE REGULATORY
PROTEIN)
4ydj HEAVY CHAIN OF
ANTIBODY 44-VRC13.01
LIGHT CHAIN OF
ANTIBODY 44-VRC13.01

(Homo
sapiens)
5 / 10 THR H  58
TYR L  96
GLY H  49
PHE H 100
ILE H  35
None
1.50A 2y7pA-4ydjH:
undetectable
2y7pA-4ydjH:
22.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3D4S_A_TIMA401_2
(BETA-2 ADRENERGIC
RECEPTOR/T4-LYSOZYME
CHIMERA)
4ydj LIGHT CHAIN OF
ANTIBODY 44-VRC13.01

(Homo
sapiens)
3 / 3 THR L 114
SER L 137
PHE L 118
None
0.81A 3d4sA-4ydjL:
undetectable
3d4sA-4ydjL:
17.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3IXL_A_PACA5000_0
(ARYLMALONATE
DECARBOXYLASE)
4ydj HEAVY CHAIN OF
ANTIBODY 44-VRC13.01

(Homo
sapiens)
5 / 10 PRO H  75
TYR H  35
VAL H  24
SER H  31
GLY H  30
None
1.47A 3ixlA-4ydjH:
undetectable
3ixlA-4ydjH:
21.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NBR_A_ASDA129_1
(STEROID
DELTA-ISOMERASE)
4ydj HEAVY CHAIN OF
ANTIBODY 44-VRC13.01
LIGHT CHAIN OF
ANTIBODY 44-VRC13.01

(Homo
sapiens)
5 / 12 PHE H 166
VAL L 195
VAL L 144
PRO L 113
PHE L 139
None
1.36A 3nbrA-4ydjH:
undetectable
3nbrA-4ydjH:
18.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3T3R_C_9PLC501_1
(CYTOCHROME P450 2A6)
4ydj HEAVY CHAIN OF
ANTIBODY 44-VRC13.01
LIGHT CHAIN OF
ANTIBODY 44-VRC13.01

(Homo
sapiens)
5 / 9 PHE L  98
PHE H  35
ILE H  35
GLY H  49
THR H  58
None
1.28A 3t3rC-4ydjL:
undetectable
3t3rC-4ydjL:
18.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4EJJ_C_NCTC501_1
(CYTOCHROME P450 2A6)
4ydj HEAVY CHAIN OF
ANTIBODY 44-VRC13.01

(Homo
sapiens)
4 / 5 PHE H  35
ILE H  35
GLY H  49
THR H  58
None
0.79A 4ejjC-4ydjH:
undetectable
4ejjC-4ydjH:
18.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4G19_D_ACTD302_0
(GLUTATHIONE
TRANSFERASE GTE1)
4ydj HEAVY CHAIN OF
ANTIBODY 44-VRC13.01

(Homo
sapiens)
3 / 3 TYR H 176
PHE H 108
ARG H 110
None
1.20A 4g19D-4ydjH:
undetectable
4g19D-4ydjH:
21.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5JLC_A_1YNA602_2
(LANOSTEROL 14-ALPHA
DEMETHYLASE)
4ydj HEAVY CHAIN OF
ANTIBODY 44-VRC13.01
LIGHT CHAIN OF
ANTIBODY 44-VRC13.01

(Homo
sapiens)
4 / 5 TYR L  87
GLY L 101
THR L 102
GLY H 174
None
0.92A 5jlcA-4ydjL:
undetectable
5jlcA-4ydjL:
17.44